...
首页> 外文期刊>Therapeutic delivery >Antimalarial solid self-emulsifying system for oral use: in vitro investigation
【24h】

Antimalarial solid self-emulsifying system for oral use: in vitro investigation

机译:口服使用抗疟型固体自乳化系统:体外调查

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: The low aqueous solubility of artemether and lumefantrine makes them less bioavailable. It is expected that by formulating self-microemulsifying drug-delivery systems (SMEDDS), their aqueous solubility and absorption will thus be enhanced. Results & methodology: Optimized liquid SMEDDS containing artemether and lumefantrine was adsorbed on Neusilin US2? employing spray drying technique to convert it into solid SMEDDS. Almost 90% of both drugs were released within 15 min in their respective official dissolution media. Drug assay and dissolution rate of solid SMEDDS remained unaltered after 3-month storage at 40°C and 75% relative humidity. Conclusion: Reconstitution of solid SMEDDS in water yielded microemulsion with a globule size of 67.74 nm. Complete and faster in vitro release of both drugs from solid SMEDDS was observed as compared with that from marketed tablets.
机译:目的:蒿甲醚和苯丙胺的水溶性较低,生物利用度较低。预计通过配制自微乳液给药系统(SMEDDS),它们的水溶性和吸收能力将因此得到增强。结果与方法:优化的含蒿甲醚和羽扇豆素的液体SMEDDS被吸附在Neusilin US2?上?采用喷雾干燥技术将其转化为固体SMEDD。几乎90%的这两种药物在15分钟内在各自的官方溶出介质中释放。在40°C和75%相对湿度下储存3个月后,固体SMEDD的药物分析和溶出率保持不变。结论:固体SMEDDS在水中的重组产生了微球大小为67.74nm的微乳。与市售片剂相比,从固体SMEDDS中观察到两种药物的体外释放完全且更快。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号